Dr. Jart+ Brand Audit: Korean Name, American Owner

Dr. Jart+ is read as Korean skincare, and it is. It is also, since 18 December 2019, wholly owned by an American house in New York. The Estée Lauder Companies bought a third of the parent in December 2015 — a minority, not control — and took the rest four years later. The brand’s own About page mentions none of it.

Snapshot

Founded

2005, Seoul, by the architect Leeo Chin Wook Lee with a Korean dermatologist; the name is “Doctor joins art”

Korean company

Have & Be Co. Ltd., Seoul

Owner

The Estée Lauder Companies Inc., NYSE: EL — one-third from December 2015, wholly owned from 18 December 2019

India launch

26 September 2024, exclusively on Nykaa

Importer named on Indian listings

None on any of the four pages examined

Price band in India

₹196 to ₹1,920 at the prices charged on 3 September 2026; ₹490 to ₹4,800 at MRP

How it started

An architect and a dermatologist started Dr. Jart+ in Seoul in 2005, and the brand’s own account of the name — “Doctor joins art” — is the tidiest summary of what it sells. The corporate vehicle is Have & Be Co. Ltd., which also owns the men’s grooming brand Do The Right Thing. Outside Korea the brand is known for one product, the Cicapair colour-correcting treatment that goes on green and settles beige.

The ownership is where most accounts go wrong. The Estée Lauder Companies acquired a stake in December 2015, and its own announcement — filed with the American securities regulator — describes that holding as one-third and the 2019 transaction as the purchase of the remaining shares. A third is not control. Dr. Jart+ stayed majority-owned by its Korean founder for four more years.

Founder ChinWook Lee’s own line on the deal was that Estée Lauder “is the ideal home for our brands”, and the brand was expected to pass $500 million of net sales in 2019.

Its owner is a substantial business. The Estée Lauder Companies reported fiscal 2026 results on 19 August 2026: net sales of $15.049 billion, up 5%, and diluted earnings of $0.50 a share against a loss of $3.15 the year before. The Lauder family holds 82% of the voting power. Dr. Jart+ appears in that release only in the brand list — no performance commentary, no strategy note. The India news in it was an agreement to acquire the rest of Forest Essentials, an Indian brand.

What they actually make

Nykaa Luxe carries 34 products: the Cicapair range built on centella, Ceramidin for the barrier, Cryo Rubber masks, Brightamin, Dermaclear, Pore Remedy and a bakuchiol cream. The hero is the Cicapair Tiger Grass Color Correcting Treatment.

Where those products are made is a question no Indian listing answers, so this page makes no statement about it — unlike Campus, which runs its own plants and says so, and unlike Bata, where the name and the company behind it are documented and separate. Here the record is simply silent.

On claims the brand publishes something, and where it publishes it matters. The American site carries four percentage results for the Cicapair treatment, all resting on one panel.

Read the verbs. “96% said” and “91% said” are people reporting how they felt. “97% showed” implies something was measured, and no instrument and no laboratory is named for either. Thirty-two women is a small panel to carry four separate percentages, and four hours is a short window for a barrier-repair claim. It is more than some imported brands publish and less than others: the brand gives a panel size, and gives no laboratory.

None of it appears on the Indian pages. What renders there is “Dermatologist Tested”, “With Cica Extracts & Niacinamide” and the product names. “Dermatologist tested” means a test happened. It does not mean the product passed, and it does not mean a dermatologist recommends it — and neither Indian page says who tested, when, on how many people, or against what.

The sun protection figure is worth a sentence of its own. One Indian retailer lists both sizes of the Cicapair treatment as SPF 22 PA++, the American site sells an SPF 30 mineral version, and Nykaa’s Indian page for the same product states no figure. A market-specific reformulation would explain it and nothing published establishes that. What an Indian buyer can act on is simpler: SPF 22 is not a sunscreen-grade number for Indian sun, and no test method, standard or laboratory is published for any Dr. Jart+ product sold here.

What Dr. Jart+ costs in India

The like-for-like comparison this audit set out to run could not be completed, and the reason is worth stating. India sells the Cicapair in 15 ml and 50 ml; the American site sells 15 mL and a 55 mL value size, and only the larger carries a published price. The two markets share no priced size.

United States, 55 ml value size

$54.00 = ₹5,150 (₹93.65/ml)

India, 15 ml at MRP

₹1,950 (₹130.00/ml)

India, 15 ml at the price charged

₹780 (₹52.00/ml)

Checked on

3 September 2026

Converted at the Federal Reserve’s H.10 rate for 28 August 2026, ₹95.38 to the dollar. The MRP figure of ₹130 per millilitre against ₹93.65 is a size effect, not a country premium — small packs cost more per millilitre everywhere, and a 15 ml against a 55 ml settles nothing about India. The figure that does mean something is ₹52 per millilitre: the smaller, structurally dearer pack costing 44% less per millilitre than the American value size. That is entirely the work of the discount.

Twenty-four of the 34 Nykaa Luxe listings rendered a price on 3 September 2026, and every single one was exactly 60% below MRP — masks, creams, serums, cleansers and kits alike, from ₹490 down to ₹196 and from ₹4,800 down to ₹1,920. Both Tira listings checked were out of stock on the same day. This audit records the observation and stops there: nothing published says why, and ELC decided in July 2026 to keep the brand and run it from Korea.

A brand its owner decided in July to keep was, seven weeks later, selling every product in India at exactly sixty per cent off.

That distance between printed and paid is documented in another category on Metro, and the lesson carries: never buy on the strike-through, and never assume a discount is permanent.

Who Dr. Jart+ is actually for

At the prices actually charged on 3 September 2026 — a median of about ₹770 across the range, with the Cicapair line running ₹280 to ₹1,280 — this is mid-range skincare in India. At MRP it is a prestige range with a median above ₹2,000, and the gap between those two sentences is the entire discount. Anyone deciding on the basis of today’s price should know it is dated.

It suits someone who wants the Cicapair colour-correcting cream specifically, which is distinctive and cheap at ₹780 for 15 ml. It suits a barrier-repair buyer less well: the results behind that claim rest on 32 people, four hours and no named laboratory, and none of that evidence appears on the page an Indian buyer is standing on.

Reputation and controversies

On animal testing this brand sits in a harsher category than most Korean skincare, and the distinction should not be flattened. PETA’s Beauty Without Bunnies directory states that “Dr. Jart is NOT Cruelty-Free” and that the company “does test on animals”, filing it under companies to avoid. Several other Korean brands are merely listed as “may not be cruelty-free”, meaning nobody has signed PETA’s assurance. This is a different classification.

Its parent’s own position sits alongside that and does not resolve it. The Estée Lauder Companies says it was one of the first cosmetics companies to eliminate animal testing more than thirty years ago, and that “we don’t test our products on animals and we don’t ask others to test for us” — while acknowledging that testing happens where a regulator legally requires it. Six of its brands hold cruelty-free certifications and Dr. Jart+ is not among them. PETA classifies the group’s other large brands the same way, so this is a house-wide position rather than anything about the brand’s Korean origin. Animal testing of cosmetics has been illegal in India since 21 May 2014 in any case.

Buying it in India

Every cosmetic imported into India must be registered before it lands — Rule 12(1) of the Cosmetics Rules 2020, notified by GSR 426(E). The application is form COS-1 and the certificate form COS-2, with COS-4 for an additional import number and COS-12 for a new cosmetic. The certificate carries an RC/COS number and is held by the Indian importer or authorised agent, never by the Korean brand and never by its American owner. The public cannot search that register, which leaves a buyer one question worth asking.

For this brand the question has nowhere else to go. Four Indian product pages were examined on 3 September 2026 across the two retailers the brand actually uses, and not one carried an importer, a manufacturer or a country of origin. Nykaa’s pages state instead that the product is “100% Authentic, directly purchased from Dr.Jart+” and name the seller as Nykaa E retail limited. That is the retailer vouching for itself, which is a different thing from a statutory declaration. Other imported Korean brands on the same shelves do print an importer’s name and address; on the pages read here, this one does not.

The corporate side adds little. The Estée Lauder Companies has had an Indian company since 2000, ELCA Cosmetics Private Limited, CIN U74999DL2000PTC103170 — but nothing on any page read connects it to these products.

Common questions

How we research and verify brand audits: our methodology.

References

1. Estée Lauder Companies announcement filed with the SEC, 18 November 2019 — the one-third stake of December 2015, the purchase of the remaining shares, the $1.7 billion enterprise value, the $500 million sales expectation and the founder’s quote
2. Moodie Davitt Report, 18 December 2019 — completion of the acquisition on that date
3. Dr. Jart+, About page, 3 September 2026 — the 2005 founding, the founder, the architect-and-dermatologist origin and the meaning of the name
4. The Estée Lauder Companies, fiscal 2026 results, 19 August 2026 — net sales of $15.049 billion, diluted earnings of $0.50 a share, and the Forest Essentials agreement
5. The Estée Lauder Companies, 5 November 2025 — the Lauder family’s 82% of voting power
6. Global Cosmetics News, 14 July 2026 — the decision against selling the three brands and the statement that Dr. Jart+ continues operating from Korea
7. Cosmetics Business, early 2026 — the earlier reporting that a sale was being explored
8. Company announcement carried by ThePrint, 26 September 2024 — the Indian launch, exclusively on Nykaa
9. Nykaa Luxe, Dr. Jart+ brand page, 3 September 2026 — 34 listings and every MRP and selling price used here
10. Nykaa, Cicapair Tiger Grass CC Treatment 15 ml, 3 September 2026 — ₹1,950 against ₹780, the authenticity wording, the seller’s name and the absence of a declaration
11. Nykaa, Ceramidin Skin Barrier Moisturizing Cream 15 ml, 3 September 2026 — ₹1,900 against ₹760 and the same absence
12. Tira, Cicapair 50 ml, 3 September 2026 — the SPF 22 PA++ listing title and the out-of-stock status
13. Tira, Cicapair 15 ml, 3 September 2026 — the second SPF 22 PA++ listing, also out of stock
14. Dr. Jart+ United States, Cicapair Soothing Color Correcting Treatment, 3 September 2026 — the $54.00 price for 55 ml, the SPF 30 mineral formulation and all four percentage claims with the 32-woman panel
15. Federal Reserve H.10, released 31 August 2026 — the 28 August 2026 rate of ₹95.38 to the dollar
16. PETA, Beauty Without Bunnies, Dr. Jart entry, 3 September 2026 — the “NOT Cruelty-Free” classification and the wording quoted here
17. The Estée Lauder Companies, Viewpoints on animal testing, 3 September 2026 — the group’s own position and the six certified brands
18. CDSCO, guidance on registration and import of cosmetics, 19 January 2021 — Rule 12(1), the COS forms and who holds the certificate
19. Advertising Standards Council of India, complaint outcomes, 3 September 2026 — the search on the term Dr. Jart